Drug intelligence / Profile preview

grass pollen allergen extract mixture

Development stage
Phase 2
Lead developer
Laboratorios Diater
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Percutaneous
01

Overview

Grass pollen allergen extract mixture is a biological allergen extract product developed by Diater (Laboratorio de Diagnóstico y Aplicaciones Terapéuticas S.A.) for use in biological standardization and diagnostic skin prick testing. It is composed of a mixture of proteins derived from various grass pollen species. The product has been evaluated in a completed Phase 2 clinical study in Spain to assess the biological activity and specificity of individual and mixed grass pollen allergen extracts using cutaneous reactivity (skin prick) testing in patients hypersensitive to grass pollen allergens, aiming to establish in-house reference preparations measured in histamine equivalent prick (HEP) units. It targets the IgE-mediated immune response in sensitized individuals (specifically allergen-specific IgE on mast cells and basophils) and is indicated for patients with allergic rhinitis and grass pollen allergy.

02

Targets

sIgG4 (Allergen-specific immunoglobulin G4)FCER1A (Fc epsilon receptor I alpha)MHC II (Major histocompatibility complex class II receptor)IgE (Immunoglobulin E)

Beyond the preview

Go deeper on grass pollen allergen extract mixture.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on grass pollen allergen extract mixture.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call